Skip to main content

Advertisement

SpringerLink
Log in

An Overview of Rare Breast Neoplasms with Radiologic-Pathologic Correlation

  • Best Practice Approaches Breast Radiology-Pathology Correlation and Management (J Scheel and MR Kilgore, Section Editors)
  • Published:
Current Breast Cancer Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This manuscript reviews rare breast malignant neoplasms and their associated imaging and pathologic findings.

Findings

The paper provides an organized framework to facilitate the radiologic-pathologic correlation process of less-common neoplasms found in the breast. 

Summary

Specifically, the imaging and pathologic findings of metaplastic carcinoma, phyllodes tumor, primary breast sarcoma, breast leukemia, breast lymphoma, and metastases to the breast from extramammary solid primary tumors are reviewed. An emphasis is made on the common trends, which are not pathognomonic, but may raise the level of suspicion for these kinds of neoplasms and guide timely, appropriate management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16
Fig. 17

Similar content being viewed by others

Abbreviations

NST:

Invasive ductal carcinoma of no special type

MPC:

Metaplastic carcinoma

MRI:

Magnetic resonance imaging

WHO:

World Health Organization

IHC:

Immunohistochemistry

PT:

Phyllodes tumor

FA:

Fibroadenoma

PBS:

Primary breast sarcomas

BA:

Angiosarcoma

BL:

Breast leukemia

FDG PET-CT:

FDG positron emission tomography

PBL:

Primary breast lymphoma

SBL:

Secondary breast lymphoma

BIA-ALCL:

Breast implant–associated anaplastic large cell lymphoma

LMP:

Latent membrane protein

BMs:

Metastases to the breast from extramammary solid primary tumors

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Beis-Filho JS GH, Mccart Peed AE, Bakha EA, Shin SJ, Sotiriou Ü, et al. Epithelial tumors of the breast WHO Classification of Ðumours Editorial Board. Breast tumours. 2019;134–8. (This classification includes the most up-to-date terminology for all metaplastic breast cancer types.)

  2. •• Donato H, Candelaria I, Oliveira P, Goncalo M, Caseiro-Alves F. Imaging findings of metaplastic carcinoma of the breast with pathologic correlation. J Belg Soc Radiol. 2018;102(1):46. (This article provides an up-to-date review of the radiologic findings of metaplastic carcinomas within the context of the current BIRADS terminology. Useful clinical and pathologic data was also supplied.)

    PubMed  PubMed Central  Google Scholar 

  3. Duman L, Gezer NS, Balci P, Altay C, Basara I, Durak MG, et al. Differentiation between phyllodes tumors and fibroadenomas based on mammographic sonographic and MRI features. Breast Care. 2016;11(2):123–7.

    PubMed  PubMed Central  Google Scholar 

  4. •• Matsumoto R, Hsieh SJK, Chala LF, de Mello GGN, de Barros N. Sarcomas of the breast: findings on mammography, ultrasound, and magnetic resonance imaging. Radiol Bras. 2018;51(6):401–6. (This review describes the most common imaging findings and clinical aspects of the sarcomas of the breast with updated BIRADS terminology.)

    PubMed  PubMed Central  Google Scholar 

  5. Surov A, Holzhausen HJ, Wienke A, Schmidt J, Thomssen C, Arnold D, et al. Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features. Br J Radiol. 2012;85(1014):e195-205.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Georgiannos SN, Chin J, Goode AW, Sheaff M. Secondary neoplasms of the breast: a survey of the 20th Century. Cancer. 2001;92(9):2259–66.

    CAS  PubMed  Google Scholar 

  7. •• Pesce K, Chico MJ, Delgado JS, Sierra ACZ, Hadad C, Wernicke A. Metastases to the breast, an uncommon diagnosis: what do radiologists need to know? Radiologia. 2019;61(4):324–32. (This manuscript summarizes imaging characteristics of histologically diagnosed metastases to the breast.)

    CAS  PubMed  Google Scholar 

  8. Leddy R, Irshad A, Rumboldt T, Cluver A, Campbell A, Ackerman S. Review of metaplastic carcinoma of the breast: imaging findings and pathologic features. J Clin Imaging Sci. 2012;2:21.

    PubMed  PubMed Central  Google Scholar 

  9. Park JM, Han BK, Moon WK, Choe YH, Ahn SH, Gong G. Metaplastic carcinoma of the breast: mammographic and sonographic findings. J Clin Ultrasound. 2000;28(4):179–86.

    CAS  PubMed  Google Scholar 

  10. McCarthy E, Kavanagh J, O’Donoghue Y, McCormack E, D’Arcy C, O’Keeffe SA. Phyllodes tumours of the breast: radiological presentation, management and follow-up. Br J Radiol. 2014;87(1044):20140239.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT. Imaging features of primary breast sarcoma. Am J Roentgenol. 2012;198(4):386–93. https://doi.org/10.2214/AJR.11.7341.

    Article  Google Scholar 

  12. Glazebrook KN, Zingula S, Jones KN, Fazzio RT. Breast imaging findings in haematological malignancies. Insights Imaging. 2014;5(6):715–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Surov A, Wienke A, Abbas J. Breast leukemia: an update. Acta Radiol. 2012;53(3):261–6.

    PubMed  Google Scholar 

  14. Bartella L, Kaye J, Perry NM, Malhotra A, Evans D, Ryan D, et al. Metastases to the breast revisited: radiological-histopathological correlation. Clin Radiol. 2003;58(7):524–31.

    CAS  PubMed  Google Scholar 

  15. DeLair DF, Corben AD, Catalano JP, Vallejo CE, Brogi E, Tan LK. Non-mammary metastases to the breast and axilla: a study of 85 cases. Mod Pathol. 2013;26(3):343–9.

    PubMed  Google Scholar 

  16. Yang WT, Hennessy B, Broglio K, Mills C, Sneige N, Davis WG, et al. Imaging differences in metaplastic and invasive ductal carcinomas of the breast. AJR Am J Roentgenol. 2007;189(6):1288–93.

    PubMed  Google Scholar 

  17. Tse GM, Tan PH, Chaiwun B, Putti TC, Lui PC, Tsang AK, et al. p63 is useful in the diagnosis of mammary metaplastic carcinomas. Pathology. 2006;38(1):16–20.

    CAS  PubMed  Google Scholar 

  18. • Andreou S, Soule E, Long D, Jasra B, Sharma S. When Something Seems Amiss: Radiology-Pathology Correlation of Metaplastic Breast Cancer. Cureus. 2020;12(5):e8239. (This case series describes occurrences of metaplastic breast cancer, highlighting the importance of a timely and accurate diagnosis.)

    PubMed  PubMed Central  Google Scholar 

  19. •• Kalambo M, Adrada BE, Adeyefa MM, Krishnamurthy S, Hess K, Carkaci S, et al. Phyllodes Tumor of the Breast: Ultrasound-Pathology Correlation. AJR Am J Roentgenol. 2018;210(4):W173–9. (This article evaluates the sonographic and histopathologic features distinguishing benign from borderline and malignant phyllodes tumors. This information was crucial for our review.)

    PubMed  Google Scholar 

  20. •• Tse G KJ, Thike AA. Fibroepithelial tumours and hamartomas of the breast. WHO Classification of Tumours Editorial Board. Breast tumours. 2019;172–6. (This classification includes the most up-to-date terminology for the phyllodes tumors.)

  21. Yabuuchi H, Soeda H, Matsuo Y, Okafuji T, Eguchi T, Sakai S, et al. Phyllodes tumor of the breast: correlation between MR findings and histologic grade. Radiology. 2006;241(3):702–9.

    PubMed  Google Scholar 

  22. Tan H, Zhang S, Liu H, Peng W, Li R, Gu Y, et al. Imaging findings in phyllodes tumors of the breast. Eur J Radiol. 2012;81(1):e62–9.

    PubMed  Google Scholar 

  23. Wurdinger S, Herzog AB, Fischer DR, Marx C, Raabe G, Schneider A, et al. Differentiation of phyllodes breast tumors from fibroadenomas on MRI. AJR Am J Roentgenol. 2005;185(5):1317–21.

    PubMed  Google Scholar 

  24. Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH et al. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J. 2020;18(4):452–78. https://doi.org/10.6004/jnccn.2020.0016.

  25. Wienbeck S, Meyer HJ, Herzog A, Nemat S, Teifke A, Heindel W, et al. Imaging findings of primary breast sarcoma: results of a first multicenter study. Eur J Radiol. 2017;88:1–7.

    PubMed  Google Scholar 

  26. Arora TK, Terracina KP, Soong J, Idowu MO, Takabe K. Primary and secondary angiosarcoma of the breast. Gland Surg. 2014;3(1):28.

    PubMed  PubMed Central  Google Scholar 

  27. • Wu WH, Ji QL, Li ZZ, Wang QN, Liu SY, Yu JF. Mammography and MRI manifestations of breast angiosarcoma. BMC Womens Health. 2019;19(1):73. (This article describes imaging findings in 17 patients with angiosarcoma, the most common primary breast sarcoma.)

    PubMed  PubMed Central  Google Scholar 

  28. Surov A, Holzhausen HJ, Ruschke K, Spielmann RP. Primary breast sarcoma: prevalence, clinical signs, and radiological features. Acta Radiol. 2011;52(6):597–601.

    PubMed  Google Scholar 

  29. Yang WT, Hennessy BT, Dryden MJ, Valero V, Hunt KK, Krishnamurthy S. Mammary angiosarcomas: imaging findings in 24 patients. Radiology. 2007;242(3):725–34.

    PubMed  Google Scholar 

  30. • Bayramoglu Z, Kebudi R, Yilmaz R, Buyukkapu Bay S, Kebudi A, Karanlik H, et al. Primary Rhabdomyosarcoma of the Breast: Imaging Findings and Literature Review. Breast Care. 2018;13(4):293–7. (This article described imaging findings in primary rhabdomyosarcoma of the breast, a rare breast sarcoma type, also a subtype of primary breast sarcoma in adolescents.)

    PubMed  PubMed Central  Google Scholar 

  31. Shah H, Bhurgri Y, Pervez S. Malignant smooth muscle tumours of soft tissue–a demographic and clinicopathological study at a tertiary care hospital. JPMA - J Pak Med Assoc. 2005;55(4):138–43.

    PubMed  Google Scholar 

  32. Sullivan HC, Edgar MA, Cohen C, Kovach CK, HooKim K, Reid MD. The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases. J Clin Pathol. 2015;68(1):44–50.

    PubMed  Google Scholar 

  33. Rossi S, Orvieto E, Furlanetto A, Laurino L, Ninfo V, Dei Tos AP. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol. 2004;17(5):547–52.

    CAS  PubMed  Google Scholar 

  34. Sebire NJ, Malone M. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J Clin Pathol. 2003;56(6):412–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Lim SZ, Selvarajan S, Thike AA, Nasir ND, Tan BK, Ong KW, et al. Breast sarcomas and malignant phyllodes tumours: comparison of clinicopathological features, treatment strategies, prognostic factors and outcomes. Breast Cancer Res Treat. 2016;159(2):229–44. https://doi.org/10.1007/s10549-016-3946-1.

    Article  PubMed  Google Scholar 

  36. Bayrak IK, Yalin T, Ozmen Z, Aksoz T, Doughanji R. Acute lymphoblastic leukemia presented as multiple breast masses. Korean J Radiol. 2009;10(5):508–10.

    PubMed  PubMed Central  Google Scholar 

  37. Valbuena JR, Admirand JH, Gualco G, Medeiros LJ. Myeloid sarcoma involving the breast. Arch Pathol Lab Med. 2005;129(1):32–8.

    PubMed  Google Scholar 

  38. Irshad A, Ackerman SJ, Pope TL, Moses CK, Rumboldt T, Panzegrau B. Rare breast lesions: correlation of imaging and histologic features with WHO classification. Radiographics. 2008;28(5):1399–414.

    PubMed  Google Scholar 

  39. Aslan H, Pourbagher A. breast involvement by hematologic malignancies: ultrasound and elastography findings with clinical outcomes. Journal of Clinical Imaging Science. 2017;7:42.

    PubMed  PubMed Central  Google Scholar 

  40. Ginat DT, Puri S. FDG PET/CT manifestations of hematopoietic malignancies of the breast. Acad Radiol. 2010;17(8):1026–30.

    PubMed  Google Scholar 

  41. Chen J, Yanuck RR 3rd, Abbondanzo SL, Chu WS, Aguilera NS. c-Kit (CD117) reactivity in extramedullary myeloid tumor/granulocytic sarcoma. Arch Pathol Lab Med. 2001;125(11):1448–52.

    CAS  PubMed  Google Scholar 

  42. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405. https://doi.org/10.1182/blood-2016-03-643544.

    Article  CAS  Google Scholar 

  43. •• Raj SD, Shurafa M, Shah Z, Raj KM, Fishman MDC, Dialani VM. Primary and Secondary Breast Lymphoma: Clinical, Pathologic, and Multimodality Imaging Review. Radiographics. 2019;39(3):610–25. (This review was important for our manuscript because it summarizes clinical and imaging differences between primary and secondary breast lymphoma combined with a review of clinical presentation.)

    PubMed  Google Scholar 

  44. Nguyen L, Papenhausen P, Shao H. The role of c-MYC in b-cell lymphomas: diagnostic and molecular aspects. Genes. 2017;8(4):05.

    Google Scholar 

  45. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–90. https://doi.org/10.1182/blood-2016-01-643569.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Xie Y, Pittaluga S, Jaffe ES. The histological classification of diffuse large B-cell lymphomas. Semin Hematol. 2015;52(2):57–66. https://doi.org/10.1053/j.seminhematol.2015.01.006.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Bacon CM, Du MQ, Dogan A. Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists. J Clin Pathol. 2007;60(4):361–72.

    CAS  PubMed  Google Scholar 

  48. Zeggai S, Harir N, Tou A, Sellam F, Mrabent MN, Salah R. Immunohistochemistry and scoring of Ki-67 proliferative index and p53 expression in gastric B cell lymphoma from Northern African population: a pilot study. J Gastrointest Oncol. 2016;7(3):462–8.

    PubMed  PubMed Central  Google Scholar 

  49. Koster A, Tromp HA, Raemaekers JM, Borm GF, Hebeda K, Mackenzie MA, et al. The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma. Haematologica. 2007;92(2):184–90.

    PubMed  Google Scholar 

  50. Shim E, Song SE, Seo BK, Kim YS, Son GS. Lymphoma affecting the breast: a pictorial review of multimodal imaging findings. J Breast Cancer. 2013;16(3):254–65.

    PubMed  PubMed Central  Google Scholar 

  51. •• Sharma B, Jurgensen-Rauch A, Pace E, Attygalle AD, Sharma R, Bommier C, et al. Breast implant–associated anaplastic large cell lymphoma: review and multiparametric imaging paradigms. Radiographics. 2020;40(3):609–28. (This article provides an up-to-date review of the radiologic findings of breast implant–associated anaplastic large cell lymphoma within the context of the current BIRADS terminology. Useful clinical data was also supplied.)

    PubMed  Google Scholar 

  52. Quesada AE, Medeiros LJ, Clemens MW, Ferrufino-Schmidt MC, Pina-Oviedo S, Miranda RN. Breast implant-associated anaplastic large cell lymphoma: a review. Mod Pathol. 2018;32(2):166–88.

    PubMed  Google Scholar 

  53. Surov A, Fiedler E, Holzhausen HJ, Ruschke K, Schmoll HJ, Spielmann RP. Metastases to the breast from non-mammary malignancies: primary tumors, prevalence, clinical signs, and radiological features. Acad Radiol. 2011;18(5):565–74.

    PubMed  Google Scholar 

  54. Williams SA, Ehlers RA 2nd, Hunt KK, Yi M, Kuerer HM, Singletary SE, et al. Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer. 2007;110(4):731–7.

    PubMed  Google Scholar 

  55. •• Kaviratna M, Jayawardena T, Dissanayake D, Wylie E. Population screening detected non-lymphomatous non-mammary metastases to the breast. A radiology multimodality pictorial essay. Clinical imaging. 2001;74:156–162. https://doi.org/10.1016/j.clinimag.2021.02.004. (This manuscript summarizes imaging characteristics of histologically diagnosed metastases to the breast.)

  56. Chung SY, Oh KK. Imaging findings of metastatic disease to the breast. Yonsei Med J. 2001;42(5):497–502.

    CAS  PubMed  Google Scholar 

  57. Abbas J, Wienke A, Spielmann RP, Bach AG, Surov A. Intramammary metastases: comparison of mammographic and ultrasound features. Eur J Radiol. 2013;82(9):1423–30.

    PubMed  Google Scholar 

  58. Mun SH, Ko EY, Han BK, Shin JH, Kim SJ, Cho EY. Breast metastases from extramammary malignancies: typical and atypical ultrasound features. Korean J Radiol. 2014;15(1):20–8.

    PubMed  PubMed Central  Google Scholar 

  59. Noguera J, Martinez-Miravete P, Idoate F, Diaz L, Pina L, Zornoza G, et al. Metastases to the breast: a review of 33 cases. Australas Radiol. 2007;51(2):133–8.

    CAS  PubMed  Google Scholar 

  60. Lee AH. The histological diagnosis of metastases to the breast from extramammary malignancies. J Clin Pathol. 2007;60(12):1333–41.

    PubMed  PubMed Central  Google Scholar 

  61. Voduc D, Cheang M, Nielsen T. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol Biomark Prev. 2008;17(2):365–73.

    CAS  Google Scholar 

  62. Robens J, Goldstein L, Gown AM, Schnitt SJ. Thyroid transcription factor-1 expression in breast carcinomas. Am J Surg Pathol. 2010;34(12):1881–5.

    PubMed  Google Scholar 

  63. Xiong TF, Pan FQ, Li D. Expression and clinical significance of S100 family genes in patients with melanoma. Melanoma Res. 2019;29(1):23–9.

    CAS  PubMed  Google Scholar 

  64. Chang PY, Wu ZZ, Sun NK, Chao CC. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression. J Cell Physiol. 2014;229(3):309–22.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Instituto Nacional de Enfermedades Neoplásicas, Av. Angamos 2520 Surquillo, 15038, Lima, Peru

    Jorge Luis Huayanay Espinoza, Fiorela Noeli Mego Ramírez & Henry Guerra Miller

  2. Department of Radiology, Jacobi Medical Center, Albert Einstein College of Medicine, NY, Bronx, USA

    Mark Guelfguat

Authors
  1. Jorge Luis Huayanay Espinoza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fiorela Noeli Mego Ramírez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henry Guerra Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mark Guelfguat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jorge Luis Huayanay Espinoza.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Best Practice Approaches Breast Radiology-Pathology Correlation and Management

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huayanay Espinoza, J.L., Mego Ramírez, F.N., Guerra Miller, H. et al. An Overview of Rare Breast Neoplasms with Radiologic-Pathologic Correlation. Curr Breast Cancer Rep 13, 296–318 (2021). https://doi.org/10.1007/s12609-021-00433-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-021-00433-z

Keywords

Search

Navigation